Orofer FCM Injection is an iron replacement medicine. It is used to treat a type of anemia where you have fewer amount of red blood cells due to insufficient iron in your body (iron-deficiency anemia). Iron is needed to produce the red blood cells that carry oxygen around your body.
Orofer FCM is product from Emcure Pharmaceuticals. Emcure, headquartered at Pune in West India, is an Indian pharmaceutical company. The company’s products include tablets, capsules (both softgel capsules and hard-gel capsules), and injectables.
Iron Deficiency Anaemia.
Anaemia is caused due to the deficiency of iron in the blood. Iron is an important mineral as it produces Haemoglobin that helps in carrying oxygen to the blood. Apart from anaemia, lack of iron in the body leads to various other problems such as weakness, fatigue, paleness, inability to concentrate, tiredness, dizziness, loss of appetite, low immunity, etc.
Symptoms of anaemia may include:
Pale looking skin
Shortness of breath
As directed by your Physician.
As directed by your Physician.
Adverse Reactions/ Side Effects
GI: Nausea, anorexia, vomiting, constipation or diarrhoea, abdominal cramps, heartburn, black stool.
Dermatologic: Allergic reactions
Warnings and Precautions
Patient w/ folate dependent tumours, erythropoietic protoporphyria, history of peptic ulcer. Pregnancy and lactation.
Patient Counselling: This drug may colour the stool black
Anaemia other than those due to Fe deficiency (e.g. megaloblastic anaemia due to vit B12 deficiency), paroxysmal nocturnal haemoglobinuria, haemosiderosis, haemochromatosis and haemoglobinopathies, active peptic ulcer, inflammatory bowel disease, including regional enteritis and ulcerative colitis, intestinal strictures and diverticulae. Patients requiring repeated blood transfusion
Ferrous fumarate: Fe chelates w/ tetracyclines, absorption of both agents may be impaired; it also chelates w/ acetohydroxamic acid, reducing the absorption of both. Reduced absorption w/ antacids and PPIs, neomycin, cholestyramine, Ca, oral Mg salts and other mineral supplements, Zn and trientine. May form insoluble complexes w/ bicarbonates, carbonates, oxalates, or phosphates, thus absorption is reduced. Increased absorption w/ ascorbic or citric acid.
Chloramphenicol delays plasma clearance and incorporation of Fe into red blood cells by interfering w/ erythropoiesis. Reduces the hypotensive effect of methyldopa. May form toxic complexes w/ dimercaprol. Reduces the absorption of fluoroquinolones, levodopa, carbidopa, entacapone, bisphosphonates, penicillamine, thyroid hormones, mycophenolate, cefdinir and Zn. May reduce the absorption of eltrombopag (give at least 4 hr apart). Folic acid: May reduce serum levels of anticonvulsants (e.g. phenobarbital, phenytoin, primidone). Reduced absorption w/ sulfasalazine. May interfere w/ the action of raltitrexed
Symptoms: Nausea, vomiting, pallor, cyanosis, melaena, shock, drowsiness, coma. CV collapse may occur in severe cases. Management: Perform gastric lavage w/ Na bicarbonate soln or milk. Administer IV fluids and electrolytes and use oxygen. Exchange transfusion and chelating agent may be used for specific therapy.